Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
60
-
Total 13F shares, excl. options
-
4,270,964
-
Shares change
-
-86,997
-
Total reported value, excl. options
-
$58,556,257
-
Value change
-
-$399,448
-
Put/Call ratio
-
6.46%
-
Number of buys
-
37
-
Number of sells
-
-27
-
Price
-
$13.71
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q2 2020
77 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q2 2020.
XBiotech Inc. - Common Shares, no par value (XBIT) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,270,964 shares
of 33,289,095 outstanding shares and own 12.83% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,299,860 shares), VANGUARD GROUP INC (892,547 shares), STATE STREET CORP (275,230 shares), GEODE CAPITAL MANAGEMENT, LLC (261,661 shares), NORTHERN TRUST CORP (233,339 shares), JANE STREET GROUP, LLC (115,274 shares), Russell Investments Group, Ltd. (112,795 shares), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (83,613 shares), AQR CAPITAL MANAGEMENT LLC (78,502 shares), and Nuveen Asset Management, LLC (67,013 shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.